A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01871311

Recruitment Status : Terminated (Primary investigator left the institution.)

First Posted : June 6, 2013

Last Update Posted : February 8, 2019

Sponsor:

Collaborator:

Novartis

Information provided by (Responsible Party):

Georgetown University

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	December 2016
Actual Study Completion Date :	December 2016

To Top